-
Notifications
You must be signed in to change notification settings - Fork 11
New issue
Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.
By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.
Already on GitHub? Sign in to your account
FDA: Purple Book Data #54
Comments
@chackoge, thanks for the request! Could you provide specifics on the fields needed. Orange Book lists the fields for each of their 3 machine-readable files: http://www.fda.gov/Drugs/InformationOnDrugs/ucm129689.htm. Which ones would be particularly applicable for your request for Purple Book? For those unfamiliar with the Purple Book... It's the Orange Book equivalent for biologics. The descriptive name for the Purple Book is “Lists of Licensed Biological Products with Reference Product Exclusivity and Biosimilarity or Interchangeability Evaluations.” To elaborate on the use case from the cited paper...
Unfortunately, this article isn't publicly accessible. Do you know what open data sources were used? Any other relevant factors we may want to point out here? |
BTW, the cited "From Scientific Discovery to Cures" paper was also mentioned in National Institute of General Medical Sciences (NIGMS) 2017 budget...
|
@dportnoy I would say all three files are relevant. I am most interested in the product, active ingredient, and patent numbers associated with these biologics but I expect that the larger community would like to see all the data in the Orange Book downloadable files made equivalently available for the Purple Book. A step further would be to retain historical patent data, i.e., list patents even if they've expired. This may not be as relevant to the Purple Book since biologics are relatively new but is certainly desirable for the Orange Book data. |
The FDA Orange Book provides downloadable data on drugs. The FDA Purple Book is available only as a spreadsheet in PDF format and has less data. Providing a machine readable version that is updated monthly and contains at least as much data as the Orange Book including listings of relevant patents would greatly support the kinds of valuable studies exemplified by Williams et al. (2015), Cell.
The text was updated successfully, but these errors were encountered: